Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
But, after burning through $50 million developing the drug, Metabolic Pharmaceuticals, which owns the patent, has continued to spruik its so-called body-enhancing benefits
It is sometimes used in conjunction with other metabolic support peptides such as MOTS-c or CJC-1295/Ipamorelin for comprehensive metabolic optimization
Clinical trials showed that AOD-9604 has no effect on IGF-1 levels and does not interfere with glucose metabolism, making it compatible with various metabolic protocols
Instead, it has relied on the rumour mill among bodybuilders in the gym and a flourishing black market in the sale of illegal peptides to help the survival of its expensive patent
The CAS number for AOD-9604 is 221231-10-3
News, Medical and Life Sciences, Obesity drug codenamed AOD 9604 highly successful in trials, 16 December 2004
US$ 20.62
US$ 23.67
US$ 29.64
US$ 28.11
US$ 29.22
US$ 24.55
US$ 28.80
US$ 27.84
US$ 22.99
US$ 20.43